VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:VHI - CA92847V5018 - Common Stock
8.92 CAD
+0.08 (+0.9%)
We assign a fundamental rating of 6 out of 10 to VHI. VHI was compared to 8 industry peers in the Health Care Technology industry. VHI gets an excellent profitability rating and is at the same time showing great financial health properties. VHI is growing strongly while it is still valued neutral. This is a good combination! With these ratings, VHI could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
VHI had positive earnings in the past year.
VHI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VHI reported negative net income in multiple years.
VHI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
VHI's Return On Assets of 0.76% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 1.08%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 2.86%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
VHI had an Average Return On Invested Capital over the past 3 years of 3.96%. This is in line with the industry average of 2.86%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROIC | 2.86% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
VHI has a better Profit Margin (2.88%) than 100.00% of its industry peers.
With an excellent Operating Margin value of 12.47%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
VHI's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 80.92%, VHI belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
In the last couple of years the Gross Margin of VHI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VHI is destroying value.
The number of shares outstanding for VHI has been increased compared to 1 year ago.
The number of shares outstanding for VHI has been increased compared to 5 years ago.
Compared to 1 year ago, VHI has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.76 indicates that VHI is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.76, VHI is doing good in the industry, outperforming 62.50% of the companies in the same industry.
The Debt to FCF ratio of VHI is 0.13, which is an excellent value as it means it would take VHI, only 0.13 years of fcf income to pay off all of its debts.
VHI has a better Debt to FCF ratio (0.13) than 87.50% of its industry peers.
VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of VHI (0.00) is better than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Altman-Z | 3.76 |
ROIC/WACC0.29
WACC9.82%
2.3 Liquidity
VHI has a Current Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
VHI's Current ratio of 1.94 is amongst the best of the industry. VHI outperforms 87.50% of its industry peers.
VHI has a Quick Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
VHI's Quick ratio of 1.94 is amongst the best of the industry. VHI outperforms 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
The earnings per share for VHI have decreased strongly by -14.29% in the last year.
The Revenue has grown by 59.34% in the past year. This is a very strong growth!
VHI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 46.32% yearly.
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
3.2 Future
Based on estimates for the next years, VHI will show a very strong growth in Earnings Per Share. The EPS will grow by 82.03% on average per year.
VHI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.30% yearly.
EPS Next Y68.34%
EPS Next 2Y107.36%
EPS Next 3Y82.03%
EPS Next 5YN/A
Revenue Next Year53.3%
Revenue Next 2Y36.21%
Revenue Next 3Y27.3%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 148.67 indicates a quite expensive valuation of VHI.
Based on the Price/Earnings ratio, VHI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 25.45, VHI is valued quite expensively.
The Price/Forward Earnings ratio is 29.64, which means the current valuation is very expensive for VHI.
Based on the Price/Forward Earnings ratio, VHI is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 34.46. VHI is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 148.67 | ||
| Fwd PE | 29.64 |
4.2 Price Multiples
100.00% of the companies in the same industry are more expensive than VHI, based on the Enterprise Value to EBITDA ratio.
VHI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VHI is cheaper than 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 46.12 | ||
| EV/EBITDA | 20.15 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VHI does not grow enough to justify the current Price/Earnings ratio.
VHI has a very decent profitability rating, which may justify a higher PE ratio.
VHI's earnings are expected to grow with 82.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.18
PEG (5Y)N/A
EPS Next 2Y107.36%
EPS Next 3Y82.03%
5. Dividend
5.1 Amount
VHI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (11/21/2025, 7:00:00 PM)
8.92
+0.08 (+0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners28.48%
Inst Owner ChangeN/A
Ins Owners11.46%
Ins Owner ChangeN/A
Market Cap561.96M
Revenue(TTM)98.17M
Net Income(TTM)2.83M
Analysts81.33
Price Target15.51 (73.88%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.71%
Min EPS beat(2)-129.12%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-61.43%
Min EPS beat(4)-129.12%
Max EPS beat(4)-28.31%
EPS beat(8)0
Avg EPS beat(8)-58.34%
EPS beat(12)1
Avg EPS beat(12)-46.79%
EPS beat(16)2
Avg EPS beat(16)-54.73%
Revenue beat(2)2
Avg Revenue beat(2)9.95%
Min Revenue beat(2)7.24%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)6
Avg Revenue beat(8)4.15%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)12
Avg Revenue beat(16)4.16%
PT rev (1m)-1.75%
PT rev (3m)-2.08%
EPS NQ rev (1m)-17.91%
EPS NQ rev (3m)-20.83%
EPS NY rev (1m)0.36%
EPS NY rev (3m)-12.77%
Revenue NQ rev (1m)2.85%
Revenue NQ rev (3m)7.68%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)3.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 148.67 | ||
| Fwd PE | 29.64 | ||
| P/S | 5.72 | ||
| P/FCF | 46.12 | ||
| P/OCF | 43.5 | ||
| P/B | 2.15 | ||
| P/tB | 11.41 | ||
| EV/EBITDA | 20.15 |
EPS(TTM)0.06
EY0.67%
EPS(NY)0.3
Fwd EY3.37%
FCF(TTM)0.19
FCFY2.17%
OCF(TTM)0.21
OCFY2.3%
SpS1.56
BVpS4.16
TBVpS0.78
PEG (NY)2.18
PEG (5Y)N/A
Graham Number2.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROCE | 4.19% | ||
| ROIC | 2.86% | ||
| ROICexc | 4.95% | ||
| ROICexgc | N/A | ||
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% | ||
| FCFM | 12.41% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Debt/EBITDA | 0.05 | ||
| Cap/Depr | 7.67% | ||
| Cap/Sales | 0.75% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.17% | ||
| Profit Quality | 430.43% | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 3.76 |
F-Score3
WACC9.82%
ROIC/WACC0.29
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y68.34%
EPS Next 2Y107.36%
EPS Next 3Y82.03%
EPS Next 5YN/A
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
Revenue Next Year53.3%
Revenue Next 2Y36.21%
Revenue Next 3Y27.3%
Revenue Next 5YN/A
EBIT growth 1Y46.83%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year69.12%
EBIT Next 3Y40.69%
EBIT Next 5YN/A
FCF growth 1Y-12.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.32%
OCF growth 3YN/A
OCF growth 5YN/A
VITALHUB CORP / VHI.CA FAQ
What is the fundamental rating for VHI stock?
ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.
Can you provide the valuation status for VITALHUB CORP?
ChartMill assigns a valuation rating of 6 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for VITALHUB CORP?
VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.
What are the PE and PB ratios of VITALHUB CORP (VHI.CA) stock?
The Price/Earnings (PE) ratio for VITALHUB CORP (VHI.CA) is 148.67 and the Price/Book (PB) ratio is 2.15.